Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.35 USD
Change Today 0.00 / 0.00%
Volume 0.0
FPMI On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

fluoropharma medical inc (FPMI) Snapshot

Open
$0.31
Previous Close
$0.35
Day High
$0.35
Day Low
$0.31
52 Week High
08/29/14 - $0.66
52 Week Low
06/9/15 - $0.21
Market Cap
10.3M
Average Volume 10 Days
44.3K
EPS TTM
--
Shares Outstanding
29.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for FLUOROPHARMA MEDICAL INC (FPMI)

Related News

No related news articles were found.

fluoropharma medical inc (FPMI) Related Businessweek News

No Related Businessweek News Found

fluoropharma medical inc (FPMI) Details

FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with primary applications in the area of cardiology in the United States. The company’s product portfolio includes BFPET, an imaging agent that has completed Phase Ia clinical trials in stress-testing for patients with known or suspected coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase II clinical trials to assess myocardial metabolism for patients with CAD. It is also developing candidates for use in the detection and treatment of vulnerable plaque. The company has license agreement with Massachusetts General Hospital. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.

5 Employees
Last Reported Date: 03/31/15
Founded in 2003

fluoropharma medical inc (FPMI) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $305.0K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $130.0K
Compensation as of Fiscal Year 2014.

fluoropharma medical inc (FPMI) Key Developments

FluoroPharma Medical, Inc. Presents at NIBA Southern California Investment Conference, Jun-24-2015

FluoroPharma Medical, Inc. Presents at NIBA Southern California Investment Conference, Jun-24-2015 . Venue: Balboa Bay Resort, 1221 West Coast Highway, Newport Beach, California, United States.

FluoroPharma Medical, Inc. Presents at 5th LD Micro Invitational Conference, Jun-02-2015 02:30 PM

FluoroPharma Medical, Inc. Presents at 5th LD Micro Invitational Conference, Jun-02-2015 02:30 PM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Blvd, Los Angeles, CA 90049, United States.

FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt

FluoroPharma Medical, Inc. filed its 10-K on Mar 31, 2015 for the period ending Dec 31, 2014. In this report its auditor, Wolf & Company, P.C., gave an unqualified opinion expressing doubt that the company can continue as a going concern.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FPMI:US $0.35 USD 0.00

FPMI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FPMI.
View Industry Companies
 

Industry Analysis

FPMI

Industry Average

Valuation FPMI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FLUOROPHARMA MEDICAL INC, please visit www.fluoropharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.